Rocking Chairs as Post-operative Treatment for Older Adults After Hip Surgery (FAIRChair)

April 21, 2026 updated by: Matthew Chrisman, University of Missouri, Kansas City

Feasibility and Acceptability of the Impact of a Rocking Chair Intervention on Recovery Compared to Standard Care of Stationary Chair on Older Adults After Elective Orthopedic Hip Surgery: A Randomized Controlled Trial

Feasibility and acceptability randomized controlled trial exploring the use of a rocking chair after a total hip arthroplasty in adults who are aged 65 or older. Primary aims include its feasibility and acceptability; exploratory aims include the impact of rocking on pain, gastrointestinal effects, anxiety, ambulation, and additional healthcare visits.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Amelia Hopper, MSN
  • Phone Number: 816-235-5700
  • Email: amhkk9@umkc.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • scheduled to undergo an elective primary total hip arthroplasty
  • Weigh less than 163kg (limit of rocking chair)
  • Able to consent
  • Able to rock with at least one leg

Exclusion Criteria:

  • Unable to sit in a chair for at least 30 minutes at a time
  • Hospitalized more than 24 hours after surgery
  • Cannot read and understand the English language
  • Planned disposition to rehabilitation facility or skilled nursing facility
  • Known vestibular dysfunction (such as Menieres, traumatic brain injury, vertigo)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Rocking chair intervention
Participants will actively rock 3 times per day for 30 minutes in a rocking chair
Other Names:
  • Rocking
Active Comparator: Attention Control Group
Sitting upright in stationary chair
Participants will sit upright in a stationary chair 3 times per day for 30 minutes
Other Names:
  • Sitting

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants that enroll and complete study assessed by Feasibility Participant Questionnaire (developed by investigators)
Time Frame: From enrollment to 31-day follow-up
Feasibility of active rocking post-operative measured by total number of participants enrolled, total percentage and number completing the study, and percent of missing data. A higher percent of missing data is a negative outcome.
From enrollment to 31-day follow-up
Total participants reporting acceptability of rocking or sitting as measured by Acceptability for Participants Questionnaire
Time Frame: From enrollment to 31-day follow-up
Acceptability of rocking or sitting after hip arthroplasty indicated by score on domains of affective, perceived effectiveness, intervention coherence, ethicality, burden, opportunity costs, self-efficacy likert scales from 1-4 (Not at all, a little, somewhat, very much). Scores from each domain are combined and summed to determine a single acceptability score (higher scores equate to higher acceptability of the intervention).
From enrollment to 31-day follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total amount of participants' Daily anxiety measured using the Anxiety subscale of the Neuro-QoL Hospital Anxiety and Depression Scale
Time Frame: From enrollment through 31-day follow-up
The participants will report their Daily anxiety assessment using the Anxiety subscale of the Neuro-QoL Hospital Anxiety and Depression Scale, which assesses self-reported fear, worry, tension, and nervousness and will be scored with a T-score with higher scores indicating more anxiety. The scores range from 0-3 (not at all, not often, sometimes, most of the time).
From enrollment through 31-day follow-up
Total participants indicating Nausea using the PROMIS Scale v1.0 GI Nausea and Vomiting 4A
Time Frame: From surgery (Day 1 of the study) to 31-day follow-up
Participants indicate Daily nausea assessment on 5-point Likert scale (never, rarely, sometimes, often, always). Higher scores indicate more Nausea.
From surgery (Day 1 of the study) to 31-day follow-up
Total participants reporting Gas/bloating via PROMIS v1.1 GI Gas and Bloating 13A
Time Frame: From surgery (Day 1 of the study) to end of 31-day follow-up
Participants reporting Daily gas/bloating assessment on 5-point Likert scale (not at all, a little bit, somewhat, quite a bit, very much). Higher scores indicate more daily gas/bloating.
From surgery (Day 1 of the study) to end of 31-day follow-up
Total participants reporting Daily pain assessed by PROMIS v2.0 pain intensity 3A
Time Frame: From surgery (Day 1 of the study) to end of 31-day follow-up
Participants reporting Daily pain assessment on 5-point likert scale (no pain, mild, moderate, severe, very severe). Higher scores equate to more daily pain experienced.
From surgery (Day 1 of the study) to end of 31-day follow-up
Total amount of participants' Daily Ambulation as measured using steps via activPAL4pro accelerometer
Time Frame: After surgery (Day 1 of the study) and up to 7 days post-surgery
The amount of participants' Daily ambulation will be assessed with the amount of steps taken per day using the triaxial accelerometer activPAL4pro. More steps per day equates to greater ambulation.
After surgery (Day 1 of the study) and up to 7 days post-surgery
Participants' self-reported Additional healthcare visits since their surgery, as assessed via phone call at 31-days post-surgery
Time Frame: From surgery (Day 1 of the study) until 31-day follow-up
The total number of Additional healthcare visits will be assessed via phone call at 31-days post-surgery using the investigator-developed question: Have you been hospitalized since you have been discharged from your hip surgery?
From surgery (Day 1 of the study) until 31-day follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Matthew Chrisman, PHD, University of Missouri, Kansas City

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 15, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

October 31, 2026

Study Registration Dates

First Submitted

February 9, 2026

First Submitted That Met QC Criteria

April 17, 2026

First Posted (Actual)

April 22, 2026

Study Record Updates

Last Update Posted (Actual)

April 27, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Will provide de-identified data to other researchers if a reasonable request is made

IPD Sharing Time Frame

Start date: March 2026 End date: up to 7 years after study ends

IPD Sharing Access Criteria

Study investigators will be able to access the IPD after it has been de-identified. They will access via password protected files.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Care

Clinical Trials on Active rocking in a rocking chair

Subscribe